Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Georgetown University
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Gruppo Italiano Malattie EMatologiche dell'Adulto
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Washington
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Weill Medical College of Cornell University
M.D. Anderson Cancer Center
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Mayo Clinic
Baylor College of Medicine
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
City of Hope Medical Center
Mayo Clinic
City of Hope Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Rigshospitalet, Denmark
City of Hope Medical Center
French Innovative Leukemia Organisation
City of Hope Medical Center
University of Pennsylvania
M.D. Anderson Cancer Center
City of Hope Medical Center
University of Washington
Dana-Farber Cancer Institute
University of California, San Diego
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Monash University